Authors: Prof Alan Parker, February 2022. In late 2019, the world could never have foreseen the impact that a new, emerging zoonotic coronavirus could possibly have across the planet. Fast forward 12 months, hundreds of millions of cases of SARS-CoV-2…
Author: Dr Rajvinder Karda, University College London, 16 December 2021 Rare disease is defined by the European Commission on Public Health as life threatening or chronically debilitating conditions whose prevalence is less than 5 per 10,000 (1). NHS England published…
Authors: Dr Christos Georgiadis, October 2021. While this year has to most felt as though life came to a standstill, the field of genome editing has experienced unprecedented momentum. With CRISPR basking in the limelight following on from the joint…
Author: Prof. Rafael J. Yáñez-Muñoz, Royal Holloway University of London, 30 August 2021 Vaccines are very much still a hot topic in the news! What is going on with vaccines for COVID-19 (more exactly against the coronavirus causing it, which…
Authors: Miss Caitlin Dop and Dr Carly Bliss, May 2021. In response to the SARS-CoV-2 pandemic, a number of COVID-19 vaccines have received emergency licensure. The majority of these vaccines deliver the genetic material encoding the SARS-CoV-2 spike protein. This…
Author: Robyn Bell, Imperial College London, 19 May 2021 Chronic pain has a high prevalence globally, with estimates of 20-30% of the population in Europe and the United States suffering from recurrent or persistent pain¹ ². Yet treatment options for…
Author: Gerry McLachlan, 3rd March 2021 The role for the BSGCT in engaging with the public is becoming ever more important as an increasing number of gene and cell therapies are either licensed for clinical use or are currently in,…
Author: Anitta Rose Chacko Technologies such as CRISPR have revolutionised precision genome editing and paved the way for treatment of previously incurable diseases and the generation of accurate disease models. Remarkably, a new study conducted by Mok et al., recently…
Author: Katie Dale With the huge effort that’s currently being spent developing more resistant T cell therapies with new targets and increased efficacy against solid tumours, it’s easy to overlook the toxicity concerns and the innovative ways scientists are tackling…
By Vered Smith Glaucoma is a condition that affects approximately 70 million people worldwide¹, –a number greater than all the people living in the U. K². But scientists led by Jiahui Wu from the University of Bristol, have come up…